Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-104060
Filing Date
2025-08-06
Accepted
2025-08-06 16:16:02
Documents
56
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-20250630.htm   iXBRL 10-Q 2386930
2 EX-31.1 asmb-ex31_1.htm EX-31.1 18800
3 EX-31.2 asmb-ex31_2.htm EX-31.2 18792
4 EX-32.1 asmb-ex32_1.htm EX-32.1 10640
5 EX-32.2 asmb-ex32_2.htm EX-32.2 10605
  Complete submission text file 0000950170-25-104060.txt   8504045

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20250630.xsd EX-101.SCH 944727
59 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20250630_htm.xml XML 1709769
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 251189799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)